miR-125b-5p enhances chemotherapy sensitivity to cisplatin by down-regulating Bcl2 in gallbladder cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-125b-5p enhances chemotherapy sensitivity to cisplatin by down-regulating Bcl2 in gallbladder cancer
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-03-03
DOI
10.1038/srep43109
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The BCL2 selective inhibitor venetoclax induces rapid onset apoptosis of CLL cells in patients via a TP53-independent mechanism
- (2016) M. A. Anderson et al. BLOOD
- Exploiting Nanotechnology for the Development of MicroRNA-Based Cancer Therapeutics
- (2016) Nikhil Tyagi et al. Journal of Biomedical Nanotechnology
- The expression of miR-125b-5p is increased in the serum of patients with chronic hepatitis B infection and inhibits the detection of hepatitis B virus surface antigen
- (2016) M. Ninomiya et al. JOURNAL OF VIRAL HEPATITIS
- Progress in BCL2 inhibition for patients with chronic lymphocytic leukemia
- (2016) Constantine S. Tam et al. SEMINARS IN ONCOLOGY
- miRNA Deregulation in Cancer Cells and the Tumor Microenvironment
- (2016) R. Rupaimoole et al. Cancer Discovery
- Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial
- (2015) Alexander Stein et al. BMC CANCER
- Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+lymphoid malignancies
- (2015) Andrew W. Roberts et al. BRITISH JOURNAL OF HAEMATOLOGY
- Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218-5p
- (2015) M-Z Ma et al. Cell Death & Disease
- MicroRNA expression and its implications for diagnosis and therapy of gallbladder cancer
- (2015) Zheng Li et al. Oncotarget
- Gallbladder Cancer in the 21st Century
- (2015) Rani Kanthan et al. Journal of Oncology
- miR-20a triggers metastasis of gallbladder carcinoma
- (2013) Yanxin Chang et al. JOURNAL OF HEPATOLOGY
- Combination chemotherapy of nafamostat mesylate with gemcitabine for gallbladder cancer targeting nuclear factor-κB activation
- (2013) Ryota Iwase et al. JOURNAL OF SURGICAL RESEARCH
- Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
- (2013) Peter E. Czabotar et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Beyond Cell Death – Antiapoptotic Bcl-2 Proteins Regulate Migration and Invasion of Colorectal Cancer Cells In Vitro
- (2013) Bruno Christian Koehler et al. PLoS One
- Small RNAs Deliver a Blow to Ovarian Cancer
- (2013) A. Kasinski et al. Cancer Discovery
- Promotion of tumor cell metastasis and vasculogenic mimicry by way of transcription coactivation by Bcl-2 and Twist1: A study of hepatocellular carcinoma
- (2011) Tao Sun et al. HEPATOLOGY
- Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model
- (2010) Li Ma et al. NATURE BIOTECHNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now